Showing results (901-910 of 1,230) with videos related to

Sort By:
Pageof 123
Cell Host & Microbe|June 26, 2018
Human Cytomegalovirus Protein UL31 Inhibits DNA Sensing of cGAS to Mediate Immune EvasionZhe-Fu Huang, Hong-Mei Zou, Bo-Wei Liao, et al.
Inorganic Chemistry|March 13, 2026
Achieving Circularly Polarized Luminescence in Chiral N,O-Ligand-Modified Indium ChloridesXin-Ping Guo, Hao-Wei Lin, Abdusalam Ablez, et al.
Technology in Cancer Research & Treatment|March 24, 2021
PD-1 Immune Checkpoint Inhibitor Therapy Malignant Tumor Based on Monotherapy and Combined Treatment ResearchYu Zhang, Guang-Ze Mou, Tian-Zhu Li, et al.
Frontiers in Psychiatry|May 20, 2020
Modulation of Stem Cells as Therapeutics for Severe Mental Disorders and Cognitive ImpairmentsYongbo Zhang, Yingying Zhao, Xiaopeng Song, et al.
Virologica Sinica|April 17, 2019
The Susceptibility of Primary Dermis Fibroblasts from the Chinese Tree Shrew to Human Cytomegalovirus InfectionShu-Wei Dong, Ling-Shuai Jiao, Ming Yang, et al.
Investigational New Drugs|October 1, 2009
Antimetastatic activity of MONCPT in preclinical melanoma mice modelXiao-Chun Yang, Chong-Xing Tu, Pei-Hua Luo, et al.
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|January 12, 2019
[Effect of Chinese Drugs for Breaking Blood Expelling Stasis on Acute Cerebral Hemorrhage: a Prospective Randomized Double-blind Controlled Study]Zhang-Yong Xia, Jing Wang, Jian-Wen Guo, et al.
Plos One|November 28, 2013
DB-02, a C-6-cyclohexylmethyl substituted pyrimidinone HIV-1 reverse transcriptase inhibitor with nanomolar activity, displays an improved sensitivity against K103N or Y181C than S-DABOsXing-Jie Zhang, Li-He Lu, Rui-Rui Wang, et al.
British Journal of Cancer|March 31, 2026
Incorporating early cfEBV DNA clearance into clinical risk stratification to tailor induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinomaWan-Ping Guo, Xuan Yu, Zi-Jian Lu, et al.
Acta Pharmacologica Sinica|January 27, 2026
Mechanisms, precision therapies, and technological frontiers in coronary atherosclerosis: a comprehensive reviewZi-Xuan Qiu, Ruo-Yu Wang, Yi Zhang, et al.
Pageof 123